Socioeconomic status and cervical cancer survival among older women: Findings from the SEER–Medicare linked data cohorts Fulltext Access 7 Pages 2006
HPV-induced carcinogenesis of the uterine cervix is associated with reduced serum ATRA level Fulltext Access 7 Pages 2006
Is intraoperative frozen section analysis of pelvic lymph nodes accurate after neoadjuvant chemotherapy in patients with cervical cancer? Fulltext Access 7 Pages 2006
The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation Fulltext Access 7 Pages 2006
HIV impact on acute morbidity and pelvic tumor control following radiotherapy for cervical cancer Fulltext Access 7 Pages 2006
HPV16 E2 gene disruption and polymorphisms of E2 and LCR: Some significant associations with cervical cancer in Indian women Fulltext Access 7 Pages 2006
Mutational analysis of TP53 and p21 in familial and sporadic ovarian cancer in Japan Fulltext Access 7 Pages 2006
Integration of HPV-16 and HPV-18 DNA in vulvar intraepithelial neoplasia Fulltext Access 7 Pages 2006
Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas Fulltext Access 7 Pages 2006
Using proteomic approaches to identify new biomarkers for detection and monitoring of ovarian cancer Fulltext Access 7 Pages 2006
A phase II study of irofulven in women with recurrent and heavily pretreated ovarian cancer Fulltext Access 7 Pages 2006
Advanced stage clear-cell epithelial ovarian cancer: The Hellenic cooperative oncology group experience Fulltext Access 7 Pages 2006
Longitudinal assessment of quality of life and lifestyle in newly diagnosed ovarian cancer patients: The roles of surgery and chemotherapy Fulltext Access 7 Pages 2006
Association between Bcl-2 expression and tumor recurrence in cervical cancer: A matched case-control study Fulltext Access 7 Pages 2006
Type II versus Type III Nerve-sparing Radical hysterectomy: Comparison of lower urinary tract dysfunctions Fulltext Access 7 Pages 2006
Feasibility of concurrent cisplatin and extended field radiation therapy (EFRT) using intensity-modulated radiotherapy (IMRT) for carcinoma of the cervix Fulltext Access 7 Pages 2006
Weekly gemcitabine and cisplatin in combination with pelvic radiation in the primary therapy of cervical cancer: A phase I trial of the Puget Sound Oncology Consortium Fulltext Access 7 Pages 2006
Germline genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes in Indian cervical cancer: Associations with tumor progression, age and human papillomavirus infection Fulltext Access 7 Pages 2006
Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: Morbidity and outcome: Results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) Fulltext Access 7 Pages 2006
Intraarterial cisplatin/nedaplatin and intravenous 5-fluorouracil with concurrent radiation therapy for patients with high-risk uterine cervical cancer Fulltext Access 7 Pages 2006
A Phase II trial of oral capecitabine in patients with platinum – and taxane – refractory ovarian, fallopian tube, or peritoneal cancer Fulltext Access 7 Pages 2006
The racial disparity in outcomes in endometrial cancer: Could this be explained on a molecular level? Fulltext Access 7 Pages 2006
Differential expression profiling of genes in a complete hydatidiform mole using cDNA microarray analysis Fulltext Access 7 Pages 2006
Evaluation of deletions in 7q11.2 and 8p12-p21 as prognostic indicators of tumour development following molar pregnancy Fulltext Access 7 Pages 2006
FDG-PET in the detection of recurrence of uterine cervical carcinoma following radiation therapy—tumor volume and FDG uptake value Fulltext Access 7 Pages 2006
Prognostic factors and impact of adjuvant chemotherapy for uterine leiomyosarcoma Fulltext Access 7 Pages 2006
P53 mutations in tissue from Danish ovarian cancer patients: From the Danish “MALOVA” ovarian cancer study Fulltext Access 7 Pages 2006
Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers Fulltext Access 7 Pages 2006
CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer Fulltext Access 7 Pages 2006
Radical pelvic resection and intraoperative radiation therapy for recurrent endometrial cancer: Technique and analysis of outcomes Fulltext Access 7 Pages 2006
Ovarian nongestational choriocarcinoma mixed with various epithelial malignancies in association with endometriosis Fulltext Access 7 Pages 2006
Good correlation of HPV DNA test between self-collected vaginal and clinician-collected cervical samples by the oligonucleotide microarray Fulltext Access 7 Pages 2006
Integrated human papillomavirus types 52 and 58 are infrequently found in cervical cancer, and high viral loads predict risk of cervical cancer Fulltext Access 7 Pages 2006
The prognostic impact of EphB2/B4 expression on patients with advanced ovarian carcinoma Fulltext Access 7 Pages 2006
Identification of prognostic factors after positive second-look surgery in epithelial ovarian carcinoma Fulltext Access 7 Pages 2006
Advanced cervical cancer treatment in Harris County: Pilot evaluation of factors that prevent optimal therapy Fulltext Access 7 Pages 2006
Influence of oral contraceptives in the development of post-molar trophoblastic neoplasia—A systematic review Fulltext Access 7 Pages 2006
Endometrial volume and vascularity measurements by transvaginal three-dimensional ultrasonography and power Doppler angiography in stimulated and tumoral endometria: Intraobserver reproducibility Fulltext Access 7 Pages 2006
Clinical results and quality of life analysis for the MVAC combination (methotrexate, vinblastine, doxorubicin, and cisplatin) in carcinoma of the uterine cervix: A Gynecologic Oncology Group study Fulltext Access 7 Pages 2006
The AP-2γ transcription factor is upregulated in advanced-stage ovarian carcinoma Fulltext Access 7 Pages 2006
Diagnostic open laparoscopy in the management of advanced ovarian cancer Fulltext Access 7 Pages 2006
“Optimal” cytoreduction for advanced epithelial ovarian cancer: A commentary Fulltext Access 7 Pages 2006
Endometrial cancer in Kentucky: The impact of age, smoking status, and rural residence Fulltext Access 7 Pages 2006
Patterns and frequency of recurrences of squamous cell carcinoma of the vulva Fulltext Access 7 Pages 2006
Semi-quantitative fluorescent PCR analysis identifies PRKAA1 on chromosome 5 as a potential candidate cancer gene of cervical cancer Fulltext Access 7 Pages 2006
CA-125 response in patients with recurrent ovarian or primary peritoneal cancer treated with pegylated liposomal doxorubicin or topotecan Fulltext Access 7 Pages 2006
Superficial (pT2a) and Deep (pT2b) Muscle Invasion in Pathological Staging of Bladder Cancer Following Radical Cystectomy Fulltext Access 7 Pages 2006
Current Role of PSA Kinetics in the Management of Patients with Prostate Cancer Fulltext Access 7 Pages 2006
A Clinical Outcomes and Cost Analysis Comparing Photoselective Vaporization of the Prostate to Alternative Minimally Invasive Therapies and Transurethral Prostate Resection for the Treatment of Benign Prostatic Hyperplasia Fulltext Access 7 Pages 2006
Patient Related Risk Factors for Recurrent Stress Urinary Incontinence Surgery in Women Treated at a Tertiary Care Center Fulltext Access 7 Pages 2006
Outcomes of Surveillance Protocol of Clinical Stage I Nonseminomatous Germ Cell Tumors-Is Shift to Risk Adapted Policy Justified? Fulltext Access 7 Pages 2006
Modeling Prostate Specific Antigen Kinetics in Patients on Active Surveillance Fulltext Access 7 Pages 2006
Significance of Macroscopic Tumor Necrosis as a Prognostic Indicator for Renal Cell Carcinoma Fulltext Access 7 Pages 2006
Real-Time Transrectal Ultrasound Guidance During Laparoscopic Radical Prostatectomy: Impact on Surgical Margins Fulltext Access 7 Pages 2006
A Novel Serum Marker, Total Prostate Secretory Protein of 94 Amino Acids, Improves Prostate Cancer Detection and Helps Identify High Grade Cancers at Diagnosis Fulltext Access 7 Pages 2006
Photodynamic Therapy for Urological Malignancies: Past to Current Approaches Fulltext Access 7 Pages 2006
The Impact of Nocturia in Patients with LUTS/BPH: Need for New Recommendations Fulltext Access 7 Pages 2006
Cystectomy for Transitional Cell Carcinoma of the Bladder: Results of a Surgery Only Series in the Neobladder Era Fulltext Access 7 Pages 2006
Uronate Peaks and Urinary Hyaluronic Acid Levels Correlate With Interstitial Cystitis Severity Fulltext Access 7 Pages 2006
Zoledronic Acid Initiated During the First Year of Androgen Deprivation Therapy Increases Bone Mineral Density in Patients With Prostate Cancer Fulltext Access 7 Pages 2006
Toremifene for the Prevention of Prostate Cancer in Men With High Grade Prostatic Intraepithelial Neoplasia: Results of a Double-Blind, Placebo Controlled, Phase IIB Clinical Trial Fulltext Access 7 Pages 2006
The Interpretation of Serum Prostate Specific Antigen in Men Receiving 5α-Reductase Inhibitors: A Review and Clinical Recommendations Fulltext Access 7 Pages 2006
Ischemia-Reperfusion Injury in Cadaveric Nonheart Beating, Cadaveric Heart Beating and Live Donor Renal Transplants Fulltext Access 7 Pages 2006
Computerized Tomography Guided Percutaneous Renal Cryoablation With the Patient Under Conscious Sedation: Initial Clinical Experience Fulltext Access 7 Pages 2006
The Natural History of Observed Enhancing Renal Masses: Meta-Analysis and Review of the World Literature Fulltext Access 7 Pages 2006
Paclitaxel and carboplatin in the adjuvant treatment of patients with high-risk stage III and IV endometrial cancer: A retrospective study Fulltext Access 7 Pages 2006
Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First Study Fulltext Access 7 Pages 2006
Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: A meta-analysis Fulltext Access 7 Pages 2006
Evaluation of predictive formulae for glomerular filtration rate for carboplatin dosing in gynecological malignancies Fulltext Access 7 Pages 2006
XRCC1 R399Q polymorphism is associated with response to platinum-based neoadjuvant chemotherapy in bulky cervical cancer Fulltext Access 7 Pages 2006
Lactate dehydrogenase 5 (LDH-5) expression in endometrial cancer relates to the activated VEGF/VEGFR2(KDR) pathway and prognosis Fulltext Access 7 Pages 2006
Incidence and management of pleural effusions after diaphragm peritonectomy or resection for advanced mullerian cancer Fulltext Access 7 Pages 2006
Long-term outcomes following conservative surgery for borderline tumor of the ovary: A large population-based study Fulltext Access 7 Pages 2006
Fertility-sparing radical abdominal trachelectomy for cervical carcinoma: Technique and review of the literature Fulltext Access 7 Pages 2006
Guidelines for reducing the risk of viral transmission during fertility treatment Fulltext Access 7 Pages 2006
Methylenetetrahydrofolate reductase C677T polymorphism and the risk of unexplained recurrent pregnancy loss: A meta-analysis Fulltext Access 7 Pages 2006
A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome Fulltext Access 7 Pages 2006
Heteroparental blastocyst production from microsurgically corrected tripronucleated human embryos Fulltext Access 7 Pages 2006
Open Radical Nephrectomy: 35 Years of Experience at the “Luciano Giuliani” Urological Department of the University of Genoa Fulltext Access 7 Pages 2006
Clinical Considerations on the Perspectives in Renal Tumour Molecular Pathology Fulltext Access 7 Pages 2006
The Prostate Cancer Prevention Trial and Its Implications for Clinical Practice: A European Consensus Fulltext Access 7 Pages 2006
LUTS and Sexual Dysfunction: What is the Link and How Can it Be Managed? Fulltext Access 7 Pages 2006